Increased Circulating Soluble Form of Fas in Patients With Dilated Cardiomyopathy
Open Access
- 1 January 1998
- journal article
- clinical trial
- Published by Japanese Circulation Society in Japanese Circulation Journal
- Vol. 62 (12), 873-876
- https://doi.org/10.1253/jcj.62.873
Abstract
To examine the prognostic role of the circulating soluble form of Fas (sFas), circulating sFas levels were measured in 33 patients with dilated cardiomyopathy (DCM) and 12 age-matched normal control subjects (NC) using an enzyme-linked immunosorbent assay (ELISA). Circulating sFas levels in DCM were significantly higher than those in NC (2.42±1.02 vs 1.66±0.20 ng/ml, p=0.015). Patients with DCM were stratified into 2 groups [group I (n=15): sFas ≥2.06 ng/ml; group II (n=18): sFas Jpn Circ J 1998; 62: 873 - 876)Keywords
This publication has 20 references indexed in Scilit:
- The cellular basis of dilated cardiomyopathy in humansJournal of Molecular and Cellular Cardiology, 1995
- Mechanism of Atrial Fibrillation and Increased Incidence of Thromboembolism in Patients With Hypertrophic Cardiomyopathy.Japanese Circulation Journal, 1995
- Increased circulating cytokines in patients with myocarditis and cardiomyopathy.Heart, 1994
- Reperfusion injury induces apoptosis in rabbit cardiomyocytes.JCI Insight, 1994
- Hypothesis: Apoptosis May be a Mechanism for the Transition to Heart Failure with Chronic Pressure OverloadJournal of Molecular and Cellular Cardiology, 1994
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosisCell, 1991
- Molecular cloning and expression of the human 55 kd tumor necrosis factor receptorCell, 1990
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Cell Metabolism, 1978